These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21419771)

  • 1. High risk of colorectal and endometrial cancer in Ashkenazi families with the MSH2 A636P founder mutation.
    Mukherjee B; Rennert G; Ahn J; Dishon S; Lejbkowicz F; Rennert HS; Shiovitz S; Moreno V; Gruber SB
    Gastroenterology; 2011 Jun; 140(7):1919-26. PubMed ID: 21419771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gynecologic malignancies in Ashkenazi families with the MSH2 A636P founder mutation.
    Lavie O; Gruber SB; Lejbkowicz F; Dishon S; Rennert G
    Am J Obstet Gynecol; 2008 Aug; 199(2):148.e1-3. PubMed ID: 18674656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome.
    Stoffel E; Mukherjee B; Raymond VM; Tayob N; Kastrinos F; Sparr J; Wang F; Bandipalliam P; Syngal S; Gruber SB
    Gastroenterology; 2009 Nov; 137(5):1621-7. PubMed ID: 19622357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population.
    Foulkes WD; Thiffault I; Gruber SB; Horwitz M; Hamel N; Lee C; Shia J; Markowitz A; Figer A; Friedman E; Farber D; Greenwood CM; Bonner JD; Nafa K; Walsh T; Marcus V; Tomsho L; Gebert J; Macrae FA; Gaff CL; Paillerets BB; Gregersen PK; Weitzel JN; Gordon PH; MacNamara E; King MC; Hampel H; De La Chapelle A; Boyd J; Offit K; Rennert G; Chong G; Ellis NA
    Am J Hum Genet; 2002 Dec; 71(6):1395-412. PubMed ID: 12454801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-amplicon MSH2 A636P mutation testing in Ashkenazi Jewish patients with colorectal cancer: role in presurgical management.
    Guillem JG; Glogowski E; Moore HG; Nafa K; Markowitz AJ; Shia J; Offit K; Ellis NA
    Ann Surg; 2007 Apr; 245(4):560-5. PubMed ID: 17414604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer risks for MLH1 and MSH2 mutation carriers.
    Dowty JG; Win AK; Buchanan DD; Lindor NM; Macrae FA; Clendenning M; Antill YC; Thibodeau SN; Casey G; Gallinger S; Marchand LL; Newcomb PA; Haile RW; Young GP; James PA; Giles GG; Gunawardena SR; Leggett BA; Gattas M; Boussioutas A; Ahnen DJ; Baron JA; Parry S; Goldblatt J; Young JP; Hopper JL; Jenkins MA
    Hum Mutat; 2013 Mar; 34(3):490-7. PubMed ID: 23255516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.
    Bonadona V; Bonaïti B; Olschwang S; Grandjouan S; Huiart L; Longy M; Guimbaud R; Buecher B; Bignon YJ; Caron O; Colas C; Noguès C; Lejeune-Dumoulin S; Olivier-Faivre L; Polycarpe-Osaer F; Nguyen TD; Desseigne F; Saurin JC; Berthet P; Leroux D; Duffour J; Manouvrier S; Frébourg T; Sobol H; Lasset C; Bonaïti-Pellié C;
    JAMA; 2011 Jun; 305(22):2304-10. PubMed ID: 21642682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of two Ashkenazi Jewish founder mutations in MSH6 gene causing Lynch syndrome.
    Raskin L; Schwenter F; Freytsis M; Tischkowitz M; Wong N; Chong G; Narod SA; Levine DA; Bogomolniy F; Aronson M; Thibodeau SN; Hunt KS; Rennert G; Gallinger S; Gruber SB; Foulkes WD
    Clin Genet; 2011 Jun; 79(6):512-22. PubMed ID: 21155762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A636P is associated with early-onset colon cancer in Ashkenazi Jews.
    Guillem JG; Rapaport BS; Kirchhoff T; Kolachana P; Nafa K; Glogowski E; Finch R; Huang H; Foulkes WD; Markowitz A; Ellis NA; Offit K
    J Am Coll Surg; 2003 Feb; 196(2):222-5. PubMed ID: 12595050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lynch Syndrome in high risk Ashkenazi Jews in Israel.
    Goldberg Y; Kedar I; Kariiv R; Halpern N; Plesser M; Hubert A; Kaduri L; Sagi M; Lerer I; Abeliovich D; Hamburger T; Nissan A; Goldshmidt H; Solar I; Geva R; Strul H; Rosner G; Baris H; Levi Z; Peretz T
    Fam Cancer; 2014 Mar; 13(1):65-73. PubMed ID: 23990280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A636P testing in Ashkenazi Jews.
    Guillem JG; Moore HG; Palmer C; Glogowski E; Finch R; Nafa K; Markowitz AJ; Offit K; Ellis NA
    Fam Cancer; 2004; 3(3-4):223-7. PubMed ID: 15516845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The founder Ashkenazi Jewish mutations in the MSH2 and MSH6 genes in Israeli patients with gastric and pancreatic cancer.
    Laitman Y; Herskovitz L; Golan T; Kaufman B; Paluch SS; Friedman E
    Fam Cancer; 2012 Jun; 11(2):243-7. PubMed ID: 22219001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma.
    Obermair A; Youlden DR; Young JP; Lindor NM; Baron JA; Newcomb P; Parry S; Hopper JL; Haile R; Jenkins MA
    Int J Cancer; 2010 Dec; 127(11):2678-84. PubMed ID: 20533284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The phenotypic expression of three MSH2 mutations in large Newfoundland families with Lynch syndrome.
    Stuckless S; Parfrey PS; Woods MO; Cox J; Fitzgerald GW; Green JS; Green RC
    Fam Cancer; 2007; 6(1):1-12. PubMed ID: 17039271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of gynecologic cancers in Danish hereditary non-polyposis colorectal cancer families.
    Boilesen AE; Bisgaard ML; Bernstein I
    Acta Obstet Gynecol Scand; 2008; 87(11):1129-35. PubMed ID: 18972272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment.
    Quehenberger F; Vasen HF; van Houwelingen HC
    J Med Genet; 2005 Jun; 42(6):491-6. PubMed ID: 15937084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study.
    International Mismatch Repair Consortium
    Lancet Oncol; 2021 Jul; 22(7):1014-1022. PubMed ID: 34111421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A common MSH2 mutation in English and North American HNPCC families: origin, phenotypic expression, and sex specific differences in colorectal cancer.
    Froggatt NJ; Green J; Brassett C; Evans DG; Bishop DT; Kolodner R; Maher ER
    J Med Genet; 1999 Feb; 36(2):97-102. PubMed ID: 10051005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic analyses in consecutive israeli jewish colorectal cancer patients.
    Fidder HH; Figer A; Geva R; Flex D; Schayek H; Avidan B; Meir SB; Friedman E
    Am J Gastroenterol; 2005 Jun; 100(6):1376-80. PubMed ID: 15929773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of pancreatic cancer in families with Lynch syndrome.
    Kastrinos F; Mukherjee B; Tayob N; Wang F; Sparr J; Raymond VM; Bandipalliam P; Stoffel EM; Gruber SB; Syngal S
    JAMA; 2009 Oct; 302(16):1790-5. PubMed ID: 19861671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.